High Operating Cash BurnSustained negative OCF and FCF mean losses are translating into real cash depletion rather than non-cash charges. Over a multi-month horizon this raises financing needs, increases dilution or refinancing risk, and constrains investments in sales, clinical studies, and commercialization.
Small And Shrinking Revenue BaseA low revenue base limits the company’s ability to absorb fixed costs and achieve operating leverage. Declining TTM revenue points to commercialization headwinds or uneven adoption, making margins and cash-flow improvements contingent on successful scale-up of installations and procedures.
Eroding Equity Base & Deep LossesA collapsing equity base combined with very large negative margins signals repeated financing or valuation pressure and sustained operating losses. This structural weakness raises the probability of future dilution, restricts strategic flexibility, and heightens execution and funding risk.